TrialBritish journal of haematology2016

A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): final results from the T- cell consortium trial.

Ranjana H Advani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.